NIH Demystifying Medicine: The Role of the Microbiome / How Gut Microbiome Controls Liver Tumors
Jeffrey Gordon, Program Director at Washington University, is known internationally for his lab's research on how gut microbial communities affect normal intestinal function. Tim Greten, senior investigator at the NIH, is an expert in gastrointestinal and tumor oncology whose lab hopes to better understand how liver tumors interact with the immune system.
Dr. Jeffrey Gordon is director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis. Often cited as the “father of the microbiome,” Gordon is known internationally for his lab’s research on how gut microbial communities affect normal intestinal function, shape various aspects of human physiology, and affect predisposition to diseases.
Dr. Tim Greten is an NIH senior investigator, deputy chief of the NCI Thoracic and GI Malignancies Branch, and a lead investigator in numerous clinical trials at the NIH Clinical Center. Greten is an expert in gastrointestinal oncology and tumor immunology with a specific research focus on hepatocellular carcinoma. His lab hopes to better understand how tumors in the liver interact with the immune system.
[Please complete our feedback form]
Related News
News Listing
Daily News ➚
5 McMaster students named McCall MacBain International Fellows
Collaborations & Partnerships, Education, Funding
5 days ago
Department of Pediatrics ➚
Behind the White Coat: A conversation with pediatric neurology resident Hannah Snyder
Education
June 25, 2024